Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis.

Rheumatology (Oxford) · 2018 · PMC6199533 · PMID 29186541

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Treatment with sarilumab monotherapy showed a trend toward greater improvement in SF-36 MCS scores vs adalimumab monotherapy at 24 weeks [ 54 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.